Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
29 April 2019 | Story Valentino Ndaba
Government to enhance PhD production
University Staff Development Programme will capacitate PhD candidates in the tripartite Global Health programme.
Can you complete a PhD in three years? The answer is “yes!” However, a challenge of this magnitude requires a proper plan.The University Staff Doctorate Programme (USDP) will provide the blueprint for that plan to five high-calibre senior staff members at the University of the Free State (UFS) who have taken on the challenge to obtain PhDs.

What is the USDP?
The University of Venda and the University of Virginia in the US have partnered with our university to help transform South African academic expertise in Global Health. Leading the cohort is the UFS Office for International Affairs. This USDP project falls under the broader University Capacity Development Programme funded by the Department of Higher Education and Training.

Candidates will be supported through mechanisms including an annual training school, visits to partner universities abroad, scholarships and reduced fees, interdisciplinary and inter-institutional co-supervision and expert advice, as well as parallel support for supervisors.

Members of the cohort
Chevon Slambee, Chief Internationalisation Officer at the Office for International Affairs, said: “These are established academics and role models in their respective areas of specialisation who have displayed strong leadership skills whilst showing a keen interest to collaborate with institutions in the US in order to advance their academic and professional careers.”

Our cohort comprises of Prof Riaz Seedat, Head: Department of Otorhinolaryngology, Dr Steven Matshidza, Head: Orthopaedic Surgery; Prof Shisana Baloyi, Head: Obstetrics and Gynaecology; Dr Edwin Turton, Head of and Senior Lecturer at the Department Anaesthesiology; and Prof Makoali Makotoko, Head: Cardiology, who will be funded by the Faculty of Health Sciences.

Carving changemakers
Three years later, this cohort will fulfil the National Development Plan to have 75% of university academic staff holding PhDs and becoming the dominant drivers of new knowledge production within the higher education science and innovation system by 2030.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept